Course – CloudTable:
Improving Long-Term Outcomes in Exudative Age-Related Macular Degeneration
Course Description “CloudTable: Improving Long-Term Outcomes in Exudative Age-Related Macular Degeneration”
The Angiogenesis Foundation convened a national expert summit of top vision health experts focused on optimizing clinician utilization and long-term treatment outcomes in exudative age-related macular degeneration. The Angiogenesis Foundation then convened an expert virtual roundtable allowing for an even larger group of leading vision health clinicians to provide an analysis of and further reflections on the summit’s findings. The clinicians were given a synopsis of the expert summit and then asked to provide their insights and contributions on the following topics:
- Real-world versus clinical trial settings and impact on long-term patient outcomes for anti-VEGF treatments for exudative AMD.
- Variations in care, especially undertreatment, as a barrier to optimal long-term vision outcomes.
- Actions to improve long-term patient outcomes, including future research using real-world evidence (RWE).
This program is an audio archive of the expert virtual roundtable on improving long-term outcomes in exudative age-related macular degeneration.
As a supplement to the audio archive, a video animation and an in-depth white paper summarize the expert findings.
This course is available on Elsevier’s CME platform.
0.50 AMA PRA Category 1 Credit(s)™